Kenneth T E Chang
Overview
Explore the profile of Kenneth T E Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan A, Tey M, Seow W, Low D, Chang K, Ng L, et al.
NeuroSci
. 2024 Nov;
4(1):54-64.
PMID: 39484294
(1) Background: Fluorescein sodium (Na-Fl) has been described as a safe and useful neurosurgical adjunct in adult neurooncology. However, its use has yet to be fully established in children. We...
2.
Wu Y, Aw S, Jain S, Ooi L, Tan E, Chang K, et al.
Front Pediatr
. 2024 Aug;
12:1378608.
PMID: 39108689
Background: Pleomorphic xanthoastrocytoma (PXA) is a rare brain tumor that accounts for <1% of all gliomas. An in-depth understanding of PXA's molecular makeup remains a work in progress due to...
3.
Lim M, Tan E, Wong R, Chang K, Fortier M, Cheong T, et al.
Pediatr Neurosurg
. 2023 Jun;
58(4):223-230.
PMID: 37315550
Introduction: Primary intracranial malignant melanoma (PIMM) is an extremely rare primary brain tumor with most cases diagnosed in adults. To date, there are only a few cases reported in the...
4.
Halepota H, Tan J, Reddy S, Tang P, Ong L, Lee Y, et al.
World J Pediatr Surg
. 2022 Dec;
4(4):e000303.
PMID: 36475241
Background: Diagnostic biopsies of pediatric anterior mediastinal masses (AMMs) are high-risk procedures in which general anesthesia (GA) is traditionally avoided. However, awareness of historically recognized risk factors and corresponding perioperative...
5.
Loh A, Angelina C, Wong M, Tan S, Sukhatme S, Yeo T, et al.
Front Oncol
. 2022 Sep;
12:939460.
PMID: 36176417
Existing marker-based methods of minimal residual disease (MRD) determination in neuroblastoma do not effectively enrich for the circulating disease cell population. Given the relative size differential of neuroblastoma tumor cells...
6.
Kuick C, Tan J, Jasmine D, Sumanty T, Ng A, Venkatesh B, et al.
BMC Cancer
. 2022 Jun;
22(1):717.
PMID: 35768791
Background: Deletion of 1p is associated with poor prognosis in neuroblastoma, however selected 1p-intact patients still experience poor outcomes. Since mutations of 1p genes may mimic the deleterious effects of...
7.
Lim J, Tan E, Ng L, Seow W, Chang K, Wong R, et al.
Front Surg
. 2022 May;
9:827675.
PMID: 35586500
Introduction: The treatment of pediatric optic pathway gliomas (OPG) is challenging. At present, most centers provide individualized treatment to maximize progression free survival (PFS) and minimize morbidity. We aim to...
8.
Wong R, Wong M, Kuick C, Saffari S, Wong M, Tan S, et al.
Front Oncol
. 2021 Nov;
11:709525.
PMID: 34722256
Neuroblastoma is the commonest extracranial pediatric malignancy. With few recurrent single nucleotide variations (SNVs), mutation-based precision oncology approaches have limited utility, but its frequent and heterogenous copy number variations (CNVs)...
9.
Oon M, Low S, Kuick C, Goh J, Chang K, McLendon R, et al.
J Neuropathol Exp Neurol
. 2021 Oct;
80(10):1000-1003.
PMID: 34599823
No abstract available.
10.
Tan N, Pratiseyo P, Wahjoepramono E, Kuick C, Goh J, Chang K, et al.
Neuropathology
. 2021 Jul;
41(4):306-314.
PMID: 34254369
Angiomatoid fibrous histiocytoma (AFH) is an uncommon soft tissue neoplasm that can exhibit diverse morphological features, including myxoid change. Rarely, the tumor occurs intracranially and poses considerable diagnostic challenges to...